
Edgewise Therapeutics, Inc.
USD36.21
-1.04 (-2.79%)
CEO
Kevin Koch
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$37.99
Prev. Close
$37.25
Day Low
$36.06
Day High
$37.99
52W Low
$12.15
52W High
$40.77
Market Cap
$3.90B
Volume
1.44M
| 17 Mar 2026 |
| Wedbush |
| Outperform |
| Outperform |
| maintain |
| 17 Mar 2026 | JP Morgan | Overweight | Overweight | maintain |
| 27 Feb 2026 | Evercore ISI Group | Outperform | Outperform | maintain |
| 14 Nov 2025 | JP Morgan | Overweight | Overweight | maintain |
| 7 Nov 2025 | RBC Capital | Outperform | Outperform | maintain |
| 7 Nov 2025 | Wedbush | Outperform | Outperform | maintain |
| 19 Aug 2025 | JP Morgan | Overweight | Overweight | maintain |